Jeffery-Smith A, Taori SK, Schelenz S, Jeffery K, Johnson EM, Borman A; Candida auris incident Management Team, Manuel R, Brown CS, 2018. Candida auris: a review of the literature. Clin Microbiol Rev 31: e00029-17.

Jeffery-SmithATaoriSKSchelenzSJefferyKJohnsonEMBormanA; Candida auris incident Management Team, ManuelRBrownCS, 2018. Candida auris: a review of the literature. Clin Microbiol Rev31: e00029-17.)| false
• Search Google Scholar
• Export Citation

Schelenz S 2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 5: 35.

SchelenzS2016. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control5: 35.)| false
• Search Google Scholar
• Export Citation

Magobo RE, Corcoran C, Seetharam S, Govender NP, 2014. Candida auris-associated candidemia, South Africa. Emerg Infect Dis 20: 1250–1251.

MagoboRECorcoranCSeetharamSGovenderNP, 2014. Candida auris-associated candidemia, South Africa. Emerg Infect Dis20: 1250–1251.)| false
• Search Google Scholar
• Export Citation

Chowdhary A 2014. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis 33: 919–926.

ChowdharyA2014. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis33: 919–926.)| false
• Search Google Scholar
• Export Citation

CDC, 2019. General Information about Candida auris | Candida auris | Fungal Diseases. Available at: https://www.cdc.gov/fungal/candida-auris/candida-auris-qanda.html. Accessed November 19, 2019.

CDC, 2019. General Information about Candida auris | Candida auris | Fungal Diseases. Available at: https://www.cdc.gov/fungal/candida-auris/candida-auris-qanda.html. Accessed November 19, 2019.)| false
• Search Google Scholar
• Export Citation

European Centre for Disease Prevention and Control, 2018. Rapid Risk Assessment: Candida auris in Healthcare Settings – Europe. Available at: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europe. Accessed November 19, 2019.

European Centre for Disease Prevention and Control, 2018. Rapid Risk Assessment: Candida auris in Healthcare Settings – Europe. Available at: https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europe. Accessed November 19, 2019.)| false
• Search Google Scholar
• Export Citation

GOV.UK, 2016. Candida auris: Laboratory Investigation, Management and Infection Prevention and Control. Available at: https://www.gov.uk/government/publications/candida-auris-laboratory-investigation-management-and-infection-prevention-and-control. Accessed November 19, 2019.

GOV.UK, 2016. Candida auris: Laboratory Investigation, Management and Infection Prevention and Control. Available at: https://www.gov.uk/government/publications/candida-auris-laboratory-investigation-management-and-infection-prevention-and-control. Accessed November 19, 2019.)| false
• Search Google Scholar
• Export Citation

Snyder GM, Wright SB, 2019. The epidemiology and prevention of Candida auris. Curr Infect Dis Rep 21: 19.

SnyderGMWrightSB, 2019. The epidemiology and prevention of Candida auris. Curr Infect Dis Rep21: 19.)| false
• Search Google Scholar
• Export Citation

Bidaud AL, Chowdhary A, Dannaoui E, 2018. Candida auris: an emerging drug resistant yeast–a mini-review. J Mycol Med 28: 568–573.

BidaudALChowdharyADannaouiE, 2018. Candida auris: an emerging drug resistant yeast–a mini-review. J Mycol Med28: 568–573.)| false
• Search Google Scholar
• Export Citation

Ledwoch K, Maillard JY, 2018. Candida auris dry surface biofilm (DSB) for disinfectant efficacy testing. Materials (Basel) 12: 18.

LedwochKMaillardJY, 2018. Candida auris dry surface biofilm (DSB) for disinfectant efficacy testing. Materials (Basel)12: 18.)| false
• Search Google Scholar
• Export Citation

Maurand A, Gagnaire J, Berthelot P, 2018. Candida auris: émergent, multi-résistant, nosocomial, transmissible. Bulletin National du Centre de Prévention des infections associées aux soins (CPias) n°10. Available at: http://www.cpias.fr/bulletin/2018/10/10-pdf/10-tous_les_articles.pdf.

MaurandAGagnaireJBerthelotP, 2018. Candida auris: émergent, multi-résistant, nosocomial, transmissible. Bulletin National du Centre de Prévention des infections associées aux soins (CPias) n°10. Available at: http://www.cpias.fr/bulletin/2018/10/10-pdf/10-tous_les_articles.pdf.)| false
• Search Google Scholar
• Export Citation

Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope W, 2012. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*. Clin Microbiol Infect 18: E246–E247.

ArendrupMCCuenca-EstrellaMLass-FlörlCHopeW, 2012. EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*. Clin Microbiol Infect18: E246–E247.)| false
• Search Google Scholar
• Export Citation

de Groot T, Puts Y, Berrio I, Chowdhary A, Meis JF, 2020. Development of Candida auris Short tandem repeat typing and its application to a global collection of isolates. mBio 11: e02971-19.

de GrootTPutsYBerrioIChowdharyAMeisJF, 2020. Development of Candida auris Short tandem repeat typing and its application to a global collection of isolates. mBio11: e02971-19.)| false
• Search Google Scholar
• Export Citation

Rudramurthy SM 2017. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 72: 1794–1801.

RudramurthySM2017. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother72: 1794–1801.)| false
• Search Google Scholar
• Export Citation

Chakrabarti A 2015. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41: 285–295.

ChakrabartiA2015. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med41: 285–295.)| false
• Search Google Scholar
• Export Citation

Lockhart SR 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64: 134–140.

LockhartSR2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis64: 134–140.)| false
• Search Google Scholar
• Export Citation

Arendrup MC, Prakash A, Meletiadis J, Sharma C, Chowdhary A, 2017. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother 61: e00485-17.

ArendrupMCPrakashAMeletiadisJSharmaCChowdharyA, 2017. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida auris and associated tentative epidemiological cutoff values. Antimicrob Agents Chemother61: e00485-17.)| false
• Search Google Scholar
• Export Citation

de Groot T, Puts Y, Berrio I, Chowdhary A, Meis JF, 2019. Development of Candida auris microsatellite typing and its application on a global collection of isolates. bioRxiv. 792663. doi: 10.1101/792663.

de GrootTPutsYBerrioIChowdharyAMeisJF, 2019. Development of Candida auris microsatellite typing and its application on a global collection of isolates. bioRxiv. 792663. doi: 10.1101/792663.)| false
• Search Google Scholar
• Export Citation

Vallabhaneni S 2016. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus–United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep 65: 1234–1237.

VallabhaneniS2016. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus–United States, May 2013–August 2016. MMWR Morb Mortal Wkly Rep65: 1234–1237.)| false
• Search Google Scholar
• Export Citation

Moore G, Schelenz S, Borman AM, Johnson EM, Brown CS, 2017. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect 97: 371–375.

MooreGSchelenzSBormanAMJohnsonEMBrownCS, 2017. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris. J Hosp Infect97: 371–375.)| false
• Search Google Scholar
• Export Citation

Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP, 2017. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55: 2996–3005.

WelshRMBentzMLShamsAHoustonHLyonsARoseLJLitvintsevaAP, 2017. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol55: 2996–3005.)| false
• Search Google Scholar
• Export Citation

Sauget M, Valot B, Bertrand X, Hocquet D, 2017. Can MALDI-TOF mass spectrometry reasonably type bacteria? Trends Microbiol 25: 447–455.

SaugetMValotBBertrandXHocquetD, 2017. Can MALDI-TOF mass spectrometry reasonably type bacteria?Trends Microbiol25: 447–455.)| false
• Search Google Scholar
• Export Citation

Quéro L, Courault P, Cellière B, Lorber S, Jany JL, Puel O, Girard V, Vasseur V, Nodet P, Mounier J, 2020. Application of MALDI-TOF MS to species complex differentiation and strain typing of food related fungi: case studies with Aspergillus section flavi species and Penicillium roqueforti isolates. Food Microbiol 86: 103311.

QuéroLCouraultPCellièreBLorberSJanyJLPuelOGirardVVasseurVNodetPMounierJ, 2020. Application of MALDI-TOF MS to species complex differentiation and strain typing of food related fungi: case studies with Aspergillus section flavi species and Penicillium roqueforti isolates. Food Microbiol86: 103311.)| false
• Search Google Scholar
• Export Citation

Al-Hatmi AMS, Normand AC, van Diepeningen AD, Hendrickx M, de Hoog GS, Piarroux R, 2015. Rapid identification of clinical members of Fusarium fujikuroi complex using MALDI-TOF MS. Future Microbiol 10: 1939–1952.

Al-HatmiAMSNormandACvan DiepeningenADHendrickxMde HoogGSPiarrouxR, 2015. Rapid identification of clinical members of Fusarium fujikuroi complex using MALDI-TOF MS. Future Microbiol10: 1939–1952.)| false
• Search Google Scholar
• Export Citation